ERBB2 and breast cancer: In the HER2+ dataset (Fig. 6A), GO analysis reveals enriched terms mainly related to NADH-related enzymes and major histocompatibility complex protein functions, which are closely associated with breast cancer [48–50] and consistent with previous observations [21].